NCT01536613View on ClinicalTrials.gov

Post Marketing Surveillance Study of Biphasic Insulin Aspart 30

CompletedOBSERVATIONAL
Enrollment

5,346

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart 30

The insulin dose and regimen were individualised at the physician's discretion. Insulin was administered by subcutaneous injection using an injection device

Trial Locations (1)

137-920

Seoul

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY